Medtronic (NYSE:MDT) recently saw a substantial price movement, climbing 10% over the last quarter. This period was marked by ...
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of ...
13d
GlobalData on MSNFDA tags Medtronic embolisation device recall as Class IThe US Food and Drug Administration (FDA) has tagged Medtronic’s recall of certain Pipeline Vantage embolisation devices as ...
"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
Medtronic (MDT) shares snapped seven straight days of losses as the stock closed xx% higher, at $xx on Thursday. The medical ...
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.
Medtronic (MDT) stock turned lower as the FDA announced a most serious type of recall involving its Pipeline Vantage 027 embolization devices. Read more here.
One scientist at the FDA's Center for Tobacco Products said the center had delayed starting new applications while staff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results